01 8Ninlaro
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 686
2018 Revenue in Millions : 543
Growth (%) : 26
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 828
2019 Revenue in Millions : 700
Growth (%) : 18
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 761
2020 Revenue in Millions : 794
Growth (%) : 3
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 743
2021 Revenue in Millions : 761
Growth (%) : -2
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 569
2022 Revenue in Millions : 743
Growth (%) : -13
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 187
2015 Revenue in Millions : 36
Growth (%) : 420
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 414
2016 Revenue in Millions : 200
Growth (%) : 107
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 526
2017 Revenue in Millions : 388
Growth (%) : 35%
LOOKING FOR A SUPPLIER?